phase readout
saveNCT06933134: Prospective Validation of a Pharmacological Biomarker for Low-Dose Rituximab in Rheumatoid Arthritis
RECRUITINGupdated 36m ago
community read0 votes
Sponsor: University Hospital, Tours. Phase: . Conditions: Rheumatoid Arthritis (RA)
view source ↗
comments(0)
5-min edit window · permanent after that